Share-based Payment Arrangement, Expense of 2seventy bio, Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
2seventy bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $2,227,000, a 52% decline year-over-year.
  • 2seventy bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $9,693,000, a 64% decline year-over-year.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12,150,000, a 62% decline from 2023.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $32,159,000, a 22% decline from 2022.
  • 2seventy bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $41,040,000, a 25% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

2seventy bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $9,693,000 $2,227,000 -$2,457,000 -52% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $12,150,000 $2,438,000 -$2,515,000 -51% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $14,665,000 $2,643,000 -$7,157,000 -73% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $21,822,000 $2,385,000 -$5,355,000 -69% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $27,177,000 $4,684,000 -$4,982,000 -52% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $32,159,000 $4,953,000 -$4,452,000 -47% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $36,611,000 $9,800,000 -$2,407,000 -20% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $39,018,000 $7,740,000 -$1,949,000 -20% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $40,967,000 $9,666,000 -$73,000 -0.75% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $41,040,000 $9,405,000 -$4,917,000 -34% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $45,957,000 $12,207,000 +$977,000 +8.7% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $44,980,000 $9,689,000 -$2,279,000 -19% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $47,259,000 $9,739,000 -$7,370,000 -43% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $54,629,000 $14,322,000 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
Q3 2021 $11,230,000 -$4,025,000 -26% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $11,968,000 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $17,109,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 $15,255,000 01 Jul 2020 30 Sep 2020 10-Q 01 Dec 2021 2021 Q3

2seventy bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $12,150,000 -$20,009,000 -62% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $32,159,000 -$8,881,000 -22% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $41,040,000 -$13,589,000 -25% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $54,629,000 -$6,368,000 -10% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $60,997,000 -$1,052,000 -1.7% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023 2022 FY
2019 $62,049,000 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.